Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of BRUSSELS REPS PHARMA is 1.0% (low). The company has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
No director data processed yet.
To directors Publicationslatest 28-12-2022
1
publications in the State GazetteUrszula KWIATKOWSKA appointed as directorAll publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsLong-established
Founded in 2003 — 23 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.0%
Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate region
+Long track record
−Higher-failure-rate sector
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Handelsbemiddeling in meubelen, huishoudelijke artikelen en ijzerwaren46150Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren46150Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Handelsbemiddeling in meubels, huishoudelijke artikelen en ijzerwaren51150
Primary activity highlighted.
Names & trade names
| Legal nameFR | BRUSSELS REPS PHARMA |
| AbbreviationFR | B.R.Pharma |
Registered office
Eiland St.-Helenastraat 5
1070 Anderlecht, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.